GVB Biopharma, represented by Becarre Natural, now delivers its range of CBD extracts from stock in Europe - quality and reactivity

GVB Biopharma, represented by Becarre Natural, now delivers its range of CBD extracts from stock in Europe -  quality and reactivity

In order to be able to satisfy even more quickly the operators of the food supplement, cosmetic and pharmaceutical markets, Becarre Natural now delivers hemp extracts from the GVB Biopharma buffer stock located in Europe, available even from 1KG packages. GVB Biopharma : the quality you can trust from the leading and trusted historical supplier

GVB Biopharma is a leading and trusted historical supplier of cannabinoid extracts using proprietary extraction processes, working in collaboration with Biosylx group involved in establishing secured sourcing network and long-term supply-chain.

Vertical integration is a key operational strategy at GVB Biopharma!
It starts with the quality control of the seed from a selection of seeds, cultivation areas, and continues at each stage of processing and development. And this integration allows an optimal traceability, as well as the compilation of all the tests carried out continuously throughout the production process. The warehouse located in Europe also allows for the quick delivery of our isolates, distillates, crude oil and products formulated in partnership with other entities of the 22nd Century group. GVB is certified GMP, non-GMO, organic [CCOF and USDA], etc..
Processed by GVB, the extracts come from certified seeds and grown in referenced areas, and are analyzed both internally and by independent ORELAP accredited laboratories.


Cannabinoid - Isolate, Distillate, oil and formulated hemp's products

Main non-psychoactive cannabinoid extracted from hemp, the cannabidiol or CBD molecule (identified in 1963) is derived from Cannabis sativa which contains more than 100 chemical compounds (mainly Cannabidiol [CBD], Cannabinol [CBN], Cannabichromene [CBC], Cannabigerol [CBG]). Also, CBD is rapidly becoming the focus of many uses in the pharmaceutical, cosmetic and of course dietary supplement fields.

Cannabidiol has no reported psychoactive effect (different receptors in the brain). Studies show that it seems to modulate the action of endocannabinoids naturally produced by the brain (regulation of the concentration of anandamide: the amount of anandamide increases, which promotes the innate endocannabinoid response of the body) but also directly on other important biological pathways.
Its action on the endocannabinoid system leads to various properties: digestion, metabolism, memory, regulation of stress and emotions... and thus plays a key role in the proper functioning of the human body.


  • CBD Isolate see
    white to lightly off-white crystalline powder, ≥ 99% CBD, THC <LOQ
  • Broad Spectrum Distillate see
    light golden viscous crystalline oil, 85-92% CBD, 2-6% minor cannabinoids, THC <LOQ
  • CBD Crude see
    dark brown thick oil, ≥ 55% CBD, THC <LOQ
  • CBC Isolate see
    golden to light orange fine-coarse powdered crystal, 95-99% CBC, THC <LOQ
  • Water Soluble CBD Powder 10% see
    fully soluble, transparent, virtually tasteless, 9-11% CBD, 0.1-0.5% minors,  THC <LOQ
    (due to a move to another production line, this product is currently unavailable for any new request)


European regulation

The use of Hemp (Cannabis sativa) in food supplements varies in Europe. All countries consider a limit on the THC content (0.2% generally). Although Cannabinoids are not authorized in FS (at of today), member states are nevertheless trying to adapt to the growing evolution of this market, and a number of applications for authorization are underway. Thus, the French authorities have authorized the registration of products including less than 50mg of CBD, even if this registration does not mean authorization.

GVB industry